MedPath

GlaxoSmithKline Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

594

CANADA:295
NMPA:4

Drug Approvals

Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets

Product Name
盐酸帕罗西汀肠溶缓释片
Approval Number
国药准字HJ20170001
Approval Date
Aug 9, 2021
NMPA

Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets

Product Name
盐酸帕罗西汀肠溶缓释片
Approval Number
国药准字HJ20170002
Approval Date
Aug 9, 2021
NMPA

Ambrisentan Tablets

Product Name
凡瑞克
Approval Number
国药准字HJ20160364
Approval Date
May 8, 2021
NMPA

Ambrisentan Tablets

Product Name
凡瑞克
Approval Number
国药准字HJ20160365
Approval Date
May 8, 2021
NMPA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.